Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of the Co-administration of Azithromycin, Albendazole and Ivermectin Versus Standard Treatment Regimens During Mass Drug Administration (MDA) in Ethiopia: a Cluster-randomized Trial

NCT03570814 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.

NCT NCT03570814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03570814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of the Co-administration of Azithromycin, Albendazole and Ivermectin Versus Standard Treatment Regimens During Mass Drug Administration (MDA) in Ethiopia: a Cluster-randomized Trial
Lead sponsor
London School of Hygiene and Tropical Medicine
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2021
Completion date
February 1, 2022
Enrollment
13,511 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic filariases, trachoma